We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Gut Microbiota Composition Indicates Efficacy of Drugs in Inflammatory Bowel Diseases

News   Jan 27, 2021 | Original story from University of Helsinki

 
Gut Microbiota Composition Indicates Efficacy of Drugs in Inflammatory Bowel Diseases
 
 
Advertisement
 

RELATED ARTICLES

Antibodies Can Attack SARS-CoV-2 Even When Their Spike Shape Changes

News

The spikes on the SARS-CoV-2 virus, which causes COVID-19, change shapes. New research reveals ways that antibodies can recognize these different shapes and block the virus and informs the design of vaccines and antiviral therapies.

READ MORE

Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection

News

Researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems and to develop therapies to block infection.

READ MORE

Having SARS-CoV-2 Antibodies Appears To Protect Well Against Reinfection

News

Prior infection with SARS-CoV-2, the virus that causes COVID-19, appears to provide protection against being reinfected with the virus for a few months, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE